Week2, 2021
1. Influenza activity is unusually low in the U.S., with 0.1% of respiratory specimens testing positive for influenza this week.
2. Clinical labs reported 23 positive specimens, comprising 52.2% Influenza A and 47.8% Influenza B.
3. Public health labs reported only three positive specimens, with 66.7% Influenza A and 33.3% Influenza B; no specific subtypes or lineages were characterized.
4. Outpatient ILI visits dropped to 1.4%, below the national baseline of 2.6% and reflecting low activity in most jurisdictions.
5. The cumulative hospitalization rate is 0.5 per 100,000 population, which is significantly lower than typical for this point in the season.
6. Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) were 14.7%, with most caused by COVID-19, exceeding the epidemic threshold of 7.0%.
7. No new influenza-associated pediatric deaths were reported this week; the season total remains at one.
8. Flu vaccination is encouraged, but no specific trends or data on vaccination uptake were highlighted.
9. Healthcare-seeking behaviors and ILI data interpretation are affected by the ongoing COVID-19 pandemic and alternative care settings.
10. Future flu activity is uncertain, but the CDC warns of potential increases in the coming months.

11. Additional factors:
12. - Influenza testing levels remain above normal, but positive results are considerably below seasonal expectations.
13. - ILI activity decreased across five regions and remained stable in others.
14. - PIC mortality remains heavily influenced by COVID-19, shaping this season's report.